Advances in Radiation Oncology · Published 2026-06-01 · DOI 10.1016/j.adro.2026.102101
Peter Orio, Grgur Mirić, Robert Galbreath, Shalini Moningi, Ryan Fiano, Kent Wallner, Martin King
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Orio, P., Mirić, G., Galbreath, R., et al. (2026). Nonprostate Cancer Deaths Best Predict Long-Term Survival in Men Aged ≤59 Years Treated With Low Dose Rate Brachytherapy With or Without Supplemental Therapies: A Mandate for Health Enhancement. Advances in Radiation Oncology. https://doi.org/10.1016/j.adro.2026.102101